Search details
1.
Mismatch Repair Deficiency in Biliary Tract Cancer: Prognostic Implications and Correlation with Histology.
Oncology
; 102(2): 157-167, 2024.
Article
in English
| MEDLINE | ID: mdl-37699372
2.
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv).
Br J Cancer
; 128(5): 877-885, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36482190
3.
Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Samples.
Clin Gastroenterol Hepatol
; 21(11): 2825-2833, 2023 10.
Article
in English
| MEDLINE | ID: mdl-36280101
4.
EUS-guided gastroenterostomy for management of malignant gastric outlet obstruction: a prospective cohort study with matched comparison with enteral stenting.
Gastrointest Endosc
; 98(3): 337-347.e5, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37094692
5.
Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients.
J Hepatol
; 71(6): 1175-1183, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31449860
6.
Pancreatic cancer: still a cold case?
Lancet Oncol
; 23(8): 964-965, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35810753
7.
Cyclophosphamide maintenance to extend combination chemotherapy-free interval in metastatic pancreatic ductal adenocarcinoma.
Dig Liver Dis
; 56(3): 509-513, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-37586911
8.
Exploring the optimal therapeutic management of stage ypIA pancreatic ductal adenocarcinoma patients in the era of primary chemotherapy.
Dig Liver Dis
; 56(2): 343-351, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-37460371
9.
Hypofractionated radiotherapy concomitant to capecitabine after induction chemotherapy for advanced pancreatic adenocarcinoma.
Clin Transl Radiat Oncol
; 47: 100778, 2024 Jul.
Article
in English
| MEDLINE | ID: mdl-38779525
10.
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma.
Dig Liver Dis
; 55(12): 1750-1756, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37121820
11.
Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes.
Cancer Chemother Pharmacol
; 92(6): 501-510, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37725113
12.
Epidemiology and geographic distribution of BRCA1-2 and DNA Damage response genes pathogenic variants in pancreatic ductal adenocarcinoma patients.
Cancer Treat Rev
; 104: 102357, 2022 Mar.
Article
in English
| MEDLINE | ID: mdl-35184001
13.
The impact of nutritional status on pancreatic cancer therapy.
Expert Rev Anticancer Ther
; 22(2): 155-167, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-34989653
14.
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index.
J Gastrointest Cancer
; 53(2): 289-298, 2022 Jun.
Article
in English
| MEDLINE | ID: mdl-33544375
15.
Treatment opportunities and future perspectives for pancreatic cancer patients with germline BRCA1-2 pathogenic variants.
Cancer Treat Rev
; 100: 102262, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-34418781
16.
Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic Adenocarcinoma.
Front Oncol
; 11: 688889, 2021.
Article
in English
| MEDLINE | ID: mdl-34568019
17.
Exploring chemotherapy holiday and drugs re-challenge in advanced pancreatic cancer patients.
Cancer Chemother Pharmacol
; 87(1): 95-101, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33159215
18.
Extensive molecular reclassification: new perspectives in small bowel adenocarcinoma?
Med Oncol
; 38(2): 17, 2021 Feb 02.
Article
in English
| MEDLINE | ID: mdl-33528694
19.
Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus.
Tumori
; 107(6): 550-555, 2021 Dec.
Article
in English
| MEDLINE | ID: mdl-33243068
20.
Developments in predictive biomarkers for hepatocellular carcinoma therapy.
Expert Rev Anticancer Ther
; 20(1): 63-74, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31910040